Innovating Works

GILMA TECHNOLOGY

Activa
ITHACA: Immuno targeting of human AML quiescent cells by a novel phage display approach. ISTITUTO EUROPEO DI ONCOLOGIA SRL tramitó un H2020: ERC-2017-PoC One main objective of our ERC Advanced Grant project (InMec, No 341131) was to determine how cancer stem cells (CSCs) contribute to tumour g...
2017-10-31 - 2019-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.